STENTYS Self-Apposing Stent Approved in Europe for Additional Coronary Indications PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--STENTYS (FR0010949404 – STNT), a medical technology company commercializing in Europe the world's first and only Self-Apposing® Stent to treat acute myocardial infarction (AMI), announced today that it received approval from its European Notified Body to expand the CE Mark indications of the Self-Apposing stent. Patients suffering from chronic chest pain ...
July 10, 2013 - Business Wire
Finding Simple Tests For Brain Disorders Turns Out To Be Complex If you're having chest pain, your doctor can test you for a heart attack. If you're having hip pain, your doctor could test for osteoarthritis. But what if you're depressed? Or anxious? Currently there are no physical tests for most disorders that affect the mind. Lab tests like these could...
July 8, 2013 - Georgia Public Broadcasting